Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS) [Phase 4]
Phase 4 trial update for AtriClip Left Atrial Appendage Exclusion used concomitantly with structural heart procedures in patients with post-…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology [NA]
Clinical trial update reporting continued access to WATCHMAN LAA closure in patients with atrial fibrillation; study status completed with r…
-
FDA approval · 2021-11-22FDA Approved: DIGOXIN — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' generic digoxin product (DIGOXIN) under an original ANDA. Digoxin is used to treat heart failure and certa…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI [Phase 4]
A Phase 4 clinical trial is evaluating dual antithrombotic therapy with dabigatran and ticagrelor in patients with acute coronary syndrome a…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Keep it SIMPLE: Improving Anti-Coagulation Medication Adherence [NA]
Completed clinical trial evaluating strategies to improve adherence to anti-coagulation medication in patients with atrial fibrillation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery [Phase 3]
Phase 3 clinical trial update evaluating landiolol for preventing postoperative atrial fibrillation in patients undergoing cardiac surgery.
-
CLINICAL_TRIALS trial_result · 2021-10-18Clinical Trial Update: A New Operation for the Treatment for Long-standing Atrial Fibrillation [NA]
A completed clinical trial update for a new operation addressing long-standing atrial fibrillation, with results posted in 2021.
-
FDA approval · 2021-10-14FDA Approved: DOFETILIDE 0.125MG — Original Application (Granules Pharmaceuticals Inc.)
FDA approved a generic version of dofetilide (0.125 mg) from Granules Pharmaceuticals Inc., expanding access to this antiarrhythmic.
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Cognitive Impairment Related to Atrial Fibrillation Prevention Trial [Phase 4]
A Phase 4 trial update related to cognitive impairment in patients with atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: ECG App Algorithms Clinical Validation Study [NA]
Clinical validation study of ECG app algorithms completed; results posted in 2021 for atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2021-09-22Clinical Trial Update: Introductory Clinical Trial for Measuring Patients Before, During, and After an Electrophysiology (EP) Procedure With a Novel, Body-Worn Sensor [NA]
A completed clinical trial evaluating a novel body-worn sensor to measure patients before, during, and after an EP procedure in atrial fibri…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Study on OMT-28 in Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation (AF) [Phase 2]
A Phase 2 trial evaluating OMT-28 for maintaining sinus rhythm in patients with persistent atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures [NA]
A completed clinical trial evaluating the impact of active temperature management during cardiac cryoablation for atrial fibrillation; resul…
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
A completed clinical trial update observing the use of non-vitamin K antagonist oral anticoagulants (NOACs) in elderly patients with atrial …
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation [NA]
A completed clinical trial comparing Microfidelity ablation technology to standard ablation catheter for atrioventricular nodal ablation in …
-
CLINICAL_TRIALS trial_result · 2021-09-01Clinical Trial Update: Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial [Phase 4]
Phase 4 trial update on subclinical atrial fibrillation and stroke prevention, status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: RIvoraxaban in Mitral Stenosis [Phase 3]
Phase 3 trial update for rivaroxaban in mitral stenosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation [NA]
Clinical trial STOP AF First evaluated cryoballoon catheter ablation in antiarrhythmic drug naive patients with paroxysmal atrial fibrillati…
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: Cryoablation System FIM/CE Mark Study [NA]
Clinical trial of Cryoablation System FIM/CE Mark study for atrial fibrillation has completed. Results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: A Fib Clinic of the Future Using KardiaPro Platform for Chronic Care of Patients With AF After Ablation Procedure [NA]
Clinical trial update on using the KardiaPro platform for chronic care of atrial fibrillation after ablation, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Esophageal Deviation in Atrial Fibrillation Ablation [NA]
Clinical trial update reporting on esophageal deviation during atrial fibrillation ablation with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Left Atrial Appendage Closure vs. Novel Anticoagulation Agents in Atrial Fibrillation [Phase 4]
Phase 4 trial comparing left atrial appendage closure with novel anticoagulation agents in atrial fibrillation has been completed.
-
FDA approval · 2021-06-03FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for Betapace (sotalol hydrochloride) filed by Legacy Pharma USA, Inc.
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCA [NA]
Clinical trial update for the CIRCA Monitoring System evaluating prevention of esophageal lesions after RFCA in atrial fibrillation patients…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Efficacy of Personalized Exercise Program and Trimetazidine in Rehabilitation of Patients After RFA of AF [NA]
Clinical trial evaluating a personalized exercise program and trimetazidine for rehabilitation after radiofrequency ablation in atrial fibri…